Straumann Holding AG Operating Income 2012-2021 | SAUHY

Straumann Holding AG annual/quarterly operating income history and growth rate from 2012 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Straumann Holding AG operating income for the quarter ending December 31, 2021 was $M, a NAN% increase year-over-year.
  • Straumann Holding AG operating income for the twelve months ending December 31, 2021 was $0M, a NAN% increase year-over-year.
  • Straumann Holding AG annual operating income for 2021 was $0.594B, a 255.54% increase from 2020.
  • Straumann Holding AG annual operating income for 2020 was $0.167B, a 57.15% decline from 2019.
  • Straumann Holding AG annual operating income for 2019 was $0.39B, a 11.23% increase from 2018.
Straumann Holding AG Annual Operating Income
(Millions of US $)
2021 $594
2020 $167
2019 $390
2018 $350
2017 $288
2016 $231
2015 $180
2014 $162
2013 $122
2012 $63
2011 $87
Straumann Holding AG Quarterly Operating Income
(Millions of US $)
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.137B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09